comparemela.com

Latest Breaking News On - Dana cormack - Page 1 : comparemela.com

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO to Participate in Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Las-vegas
Chris-brinzey
Dana-cormack
Bofa-securities-health-care-conference
Genes-genetic-medicines-forum
Nasdaq
Corporate-communications
Securities-health-care-conference
Genes-genetic-medicines

REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights

ROCKVILLE, Md., May 1, 2024 /PRNewswire/ REGENXBIO Inc. today announced that it will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to discuss its financial results for the.

Chris-brinzey
Dana-cormack
Corporate-communications
Nasdaq
Markets

REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chris-brinzey
Dana-cormack
Nasdaq
Corporate-communications
Annual-genetic-medicines
Cell-therapy-manufacturing-summit
Gene-therapy
Every-stage

REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health.

United-states
Japan
Boston
Massachusetts
Rockville
Dana-cormack
Jeffreys-heier
Chris-brinzey
Exchange-commission
Drug-administration
Nasdaq
European-medicines-agency

REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Cantor Fitzgerald s Virtual DMD and Other Dystrophy Days on Wednesday,.

Dana-cormack
Corporate-communications
Nasdaq
Cantor-fitzgerald

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.